Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells.
Sibilla MolonPaola BrunMelania ScarpaDario BizzottoGaia ZuccolottoMarco ScarpaAngelo Paolo Dei TosImerio AngrimanAntonio RosatoPaola BraghettaIgnazio CastagliuoloPaolo BonaldoPublished in: The Journal of pathology (2023)
Despite a number of studies providing evidence that the extracellular matrix (ECM) is an active player in the pathogenesis of intestinal inflammation, knowledge on the actual contribution of specific ECM molecules in the progression of inflammatory bowel disease (IBD) remains scant. Here, we investigated the role of a major ECM protein, collagen VI (ColVI), in gut homeostasis and elucidated the impact of its deregulation on the pathophysiology of IBD. To this end, we combined in vivo and ex vivo studies on wild type and ColVI-deficient (Col6a1 -/- ) mice both under physiological conditions and during experimentally induced acute colitis and its subsequent recovery, by means of gut histology and immunostaining, gene expression, bone marrow transplantation, flow cytometry of immune cell subpopulations, and lymph flow assessment. We found that ColVI displayed dynamic expression and ECM deposition during the acute inflammatory and recovery phases of experimentally induced colitis, whereas the genetic ablation of ColVI in Col6a1 null mice impaired the functionality of lymphatic vessels, which in turn affected the resolution of inflammation during colitis. Based on these findings, we investigated ColVI expression and deposition in ileal specimens from two cohorts of patients affected by Crohn's disease (CD) and correlated ColVI abundance to clinical outcome. Our results show that high ColVI immunoreactivity in ileal biopsies of CD patients at diagnosis correlates with increased risk of surgery and that ColVI expression in biopsies taken at the resection margin during surgery, and showing inactive disease, predict disease recurrence. Our data unveil a key role for ColVI in the intestinal microenvironment, where it is involved in lymphangiogenesis and intestinal inflammation. Altogether, these findings point at the dysregulation of ColVI expression as a novel factor contributing to the onset and maintenance of inflammation in CD via mechanisms impinging on the modulation of inflammatory cell recruitment and function. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Keyphrases
- extracellular matrix
- oxidative stress
- poor prognosis
- end stage renal disease
- gene expression
- wild type
- newly diagnosed
- flow cytometry
- chronic kidney disease
- binding protein
- ulcerative colitis
- stem cells
- ejection fraction
- healthcare
- coronary artery bypass
- induced apoptosis
- minimally invasive
- systematic review
- randomized controlled trial
- prognostic factors
- single cell
- electronic health record
- acute coronary syndrome
- adipose tissue
- nk cells
- type diabetes
- ultrasound guided
- mesenchymal stem cells
- intensive care unit
- high fat diet induced
- liver failure
- patient reported outcomes
- skeletal muscle
- cell therapy
- coronary artery disease
- genome wide
- signaling pathway
- atrial fibrillation
- endoplasmic reticulum stress
- mass spectrometry
- data analysis